|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1998-4-29
|
|
pubmed:abstractText |
Mass screening of infants for neuroblastoma began in Japan after studies suggested that survival rates could be improved by early detection. This study was initiated in 1991 to test the methodology and feasibility of screening for neuroblastoma within the U. S. health care system.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1593-602
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9554539-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9554539-Feasibility Studies,
pubmed-meshheading:9554539-Female,
pubmed-meshheading:9554539-Homovanillic Acid,
pubmed-meshheading:9554539-Humans,
pubmed-meshheading:9554539-Infant,
pubmed-meshheading:9554539-Male,
pubmed-meshheading:9554539-Mass Screening,
pubmed-meshheading:9554539-Neuroblastoma,
pubmed-meshheading:9554539-Sensitivity and Specificity,
pubmed-meshheading:9554539-Texas,
pubmed-meshheading:9554539-Vanilmandelic Acid
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
|
|
pubmed:affiliation |
Division of Pediatrics, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
